Literature DB >> 1710233

Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoantibody-associated cross-reactive idiotypes.

T J Kipps1, S F Duffy.   

Abstract

We examined human tonsillar B cells for expression of autoantibody heavy-chain or kappa light-chain cross-reactive idiotypes (CRIs), respectively defined by murine MAbs G6 or 17.109. We find 17.109 or G6 each specifically binds a subpopulation of B cells, respectively reacting with 3.8 +/- 3% (mean +/- SD) or 2.0 +/- 1.2% of all tonsillar lymphocytes. Cells reactive with both 17.109 and G6 comprise only 0.4 +/- 0.3% of tonsillar lymphocytes. Although each tested specimen had 17.109-positive cells, 2 of 19 tonsils (11%) did not have any G6-reactive cells. We find that CRI-positive cells and CD5 B cells both co-express slgD but fail to bind peanut agglutinin or MAbs specific for CD10, indicating that both cell types reside in the mantle zones of secondary B cell follicles. However, less than half of the B cells bearing one or both of these CRIs express detectable levels of CD5. Nevertheless, we find that G6-reactive lymphocytes constitute a multiclonal population of cells that express homologous heavy chain variable region genes, each rearranged to one of several distinct and apparently nonmutated D and JH gene segments. Collectively, these studies indicate that expression of nondiversified autoantibody-encoding variable region genes may not be an exclusive property of B cells that bear detectable levels of the CD5 surface antigen.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710233      PMCID: PMC296965          DOI: 10.1172/JCI115239

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  58 in total

1.  Nucleotide sequences of eight human natural autoantibody VH regions reveals apparent restricted use of VH families.

Authors:  I Sanz; P Casali; J W Thomas; A L Notkins; J D Capra
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

2.  Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia.

Authors:  T J Kipps; E Tomhave; L F Pratt; S Duffy; P P Chen; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

3.  Autoantibody-associated cross-reactive idiotypes expressed at high frequency in chronic lymphocytic leukemia relative to B-cell lymphomas of follicular center cell origin.

Authors:  T J Kipps; B A Robbins; P Kuster; D A Carson
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

4.  Ig V region gene expression in small lymphocytic lymphoma with little or no somatic hypermutation.

Authors:  L F Pratt; L Rassenti; J Larrick; B Robbins; P M Banks; T J Kipps
Journal:  J Immunol       Date:  1989-07-15       Impact factor: 5.422

5.  Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies.

Authors:  J H Antin; S G Emerson; P Martin; N Gadol; K A Ault
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

6.  Human immunoglobulin D segments encoded in tandem multigenic families.

Authors:  U Siebenlist; J V Ravetch; S Korsmeyer; T Waldmann; P Leder
Journal:  Nature       Date:  1981-12-17       Impact factor: 49.962

7.  Antigenic phenotype and functional characterization of human tonsil B cells.

Authors:  N Gadol; M A Peacock; K A Ault
Journal:  Blood       Date:  1988-04       Impact factor: 22.113

8.  The human lymph node germinal center cell: characterization and isolation by using two-color flow cytometry.

Authors:  D S Weinberg; K A Ault; M Gurley; G S Pinkus
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

9.  Dispersed localization of D segments in the human immunoglobulin heavy-chain locus.

Authors:  F Matsuda; K H Lee; S Nakai; T Sato; M Kodaira; S Q Zong; H Ohno; S Fukuhara; T Honjo
Journal:  EMBO J       Date:  1988-04       Impact factor: 11.598

10.  Organization of human immunoglobulin heavy chain diversity gene loci.

Authors:  Y Ichihara; H Matsuoka; Y Kurosawa
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

View more
  20 in total

1.  Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody.

Authors:  W A Marasco; J Bagley; C Zani; M Posner; L Cavacini; W A Haseltine; J Sodroski
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

2.  Evidence that the V kappa III gene usage is nonstochastic in both adult and newborn peripheral B cells and that peripheral CD5+ adult B cells are oligoclonal.

Authors:  J C Weber; G Blaison; T Martin; A M Knapp; J L Pasquali
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 3.  Growth and survival of B-chronic lymphocytic leukaemia cells.

Authors:  O Söderberg
Journal:  Med Oncol       Date:  1998-07       Impact factor: 3.064

4.  Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells.

Authors:  H P Brezinschek; S J Foster; R I Brezinschek; T Dörner; R Domiati-Saad; P E Lipsky
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

5.  Expression of the immunoglobulin VH gene 51p1 is proportional to its germline gene copy number.

Authors:  E H Sasso; T Johnson; T J Kipps
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

6.  Genetic analysis of the variable region genes encoding a monospecific human natural anti-DNA antibody.

Authors:  M D Daley; V Misener; T Olee; P P Chen; K A Siminovitch
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

7.  Restricted use of fetal VH3 immunoglobulin genes by unselected B cells in the adult. Predominance of 56p1-like VH genes in common variable immunodeficiency.

Authors:  J Braun; L Berberian; L King; I Sanz; H L Govan
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

8.  Effect of 51p1-related gene copy number (V1-69 locus) on production of hepatitis C-associated cryoglobulins.

Authors:  E H Sasso; P Ghillani; L Musset; J C Piette; P Cacoub
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

9.  A recombinant human Fab expressed in Escherichia coli neutralizes rabies virus.

Authors:  S C Cheung; B Dietzschold; H Koprowski; A L Notkins; R F Rando
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

10.  VH usage and somatic hypermutation in peripheral blood B cells of patients with rheumatoid arthritis (RA).

Authors:  S C Huang; R Jiang; W O Hufnagle; D E Furst; K R Wilske; E C Milner
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.